How much did Biolevate raise?

Biolevate raised €30M at Series A, announced 22 September 2026.

Who founded Biolevate?

Joël Belafa is Co-founder & CEO of Biolevate.

What does Biolevate do?

Biolevate operates in HealthTech and is based in France.

FundedStartupsDaily / HealthTech / Biolevate

Biolevate raises €30M

Biolevate announced a Series A round of €30M on 22 September 2026. The company operates in HealthTech and is based in France. It was founded by Joël Belafa, Co-founder & CEO. Announced today.

Raised

€30M

Stage

Series A

Industry

HealthTech

Country

France

Founder

Joël Belafa

Co-founder & CEO, Biolevate

LinkedIn profile biolevate.com

Outreach angles

-Joël Belafa and the Biolevate founding team are former Dataiku engineers and AI researchers.
-Belafa's team has filed seven patent applications, two of them in Europe, since founding the company.
-Biolevate doubled headcount over the past year and opened a new Boston office after its €30M Series A.